Development of Hepatocellular Carcinoma after Interferon Therapy in Chronic Hepatitis C

Publisher： Karger

E-ISSN： 1423-0100|48|1|59-63

ISSN： 0300-5526

Source： Intervirology, Vol.48, Iss.1, 2005-03, pp. : 59-63

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recurrence Rate and Prognosis of Patients with Hepatocellular Carcinoma That Developed after Elimination of Hepatitis C Virus RNA by Interferon Therapy

By  

Oncology, Vol. 65, Iss. 3, 2003-12 ,pp. : 204-210

Karger

Access to resources Recommend Favorite

Interferon for Decreasing the Incidence of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C

By  

Oncology, Vol. 62, Iss. 1, 2002-01 ,pp. : 87-93

Karger

Access to resources Recommend Favorite

Suppression of HCV‐related HCC by IFN therapy

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 2, 2015-01 ,pp. : 152-161

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of the Dose and Duration of Interferon-Alpha Therapy on the Incidence of Hepatocellular Carcinoma in Noncirrhotic Patients with a Nonsustained Response to Interferon for Chronic Hepatitis C

By  

Oncology, Vol. 61, Iss. 2, 2001-08 ,pp. : 134-142

Karger

Access to resources Recommend Favorite

Effect of Long-Term Postoperative Interferon Therapy on Intrahepatic Recurrence and Survival Rate after Resection of Hepatitis C Virus-Related Hepatocellular Carcinoma

By  

Intervirology, Vol. 48, Iss. 1, 2005-03 ,pp. : 71-75

Karger

Access to resources Recommend Favorite